Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Shelter Pharma Ltd
Your Vote -
Buy
40.00%
Hold
20.00%
Sell
40.00%
40.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shelter Pharma - Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Re
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Change in Management
-
Shelter Pharma - Outcome Of The Board Meeting And Submission Of The\r\nAudited Standalone Financial Results For The Half Year
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of The Audited Standalone Financial Re
-
Shelter Pharma - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 28Th May, 2026
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015-Continuous Positive Customer Feedback On Com
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( LODR ) Regulations 2015 - Participation In Iphex 2026 Internation
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015\r\nReceipt Work Order Pursuant To Tender Pro
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended May 05, 2026
-
Shelter Pharma - Intimation Under Regulation 30 For Successfully Conducted A CME Programme In Patna Bihar On 11Th May 2026
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended May 01, 2026
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (LODR) Regulation, 2015- New Product Launch.
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 05, 2026 For Conversion Of 111
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, May 01, 2026.
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Shelter Pharma - Intimation Under Regulation 30 Update On Export Operation
-
Shelter Pharma - Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion Plans
-
Shelter Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclousure Requirements ) Regulation 2015 F
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements ) Regulation, 2015
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclousures Requirements) Regulations, 201
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( LODR ) New Product Now Available In The Market
-
Shelter Pharma - Intimitation Under Regulation 30 Third Party Food Safety Audit Under FSSAI Regulatory Framework
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI ( Listing Obligation And Disclousure Requirements) Regulation 2015 -
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 07, 2026
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Shelter Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, March 07, 2026
Key fundamentals
Evaluate the intrinsic value of Shelter Pharma Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 77.433 | 43.7647 | 36.3931 | 16.2947 | 8.9366 |
| Liabilities | 77.433 | 43.7647 | 36.3931 | 16.2947 | 8.9366 |
| Equity | 16.6118 | 11.5598 | 11.5598 | 7.7438 | 0.4839 |
| Gross Profit | 12.726 | 10.0677 | 8.5714 | 8.0574 | 2.9223 |
| Net Profit | 9.0272 | 7.2374 | 6.2002 | 5.7833 | 1.8569 |
| Cash From Operating Activities | -12.4801 | 5.4822 | -1.8502 | 0.0033 | 0 |
| NPM(%) | 12.34 | 14.28 | 15.49 | 15.99 | 6.17 |
| Revenue | 73.1336 | 50.6602 | 40.0229 | 36.1527 | 30.0554 |
| Expenses | 60.4076 | 40.5925 | 31.4515 | 28.0953 | 27.1331 |
| ROE(%) | 17.21 | 13.79 | 11.82 | 11.02 | 3.54 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 704.30 | -2.42 | 0.00 | 17.12 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 108.05 | -1.05 | 3619.00 | 62.39 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.50 | -1.30 | 0.00 | 129.54 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 770.75 | 1.41 | 0.00 | 58.83 | -363.15 | 0.00 |
Company Info
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
Read More
Parent Organisation
Shelter Pharma Ltd.
Founded
12/10/2007
Managing Director
Mr.Mustaqim Nisarahmed Sabugar
NSE Symbol
FAQ
The current price of Shelter Pharma Ltd is
The 52-week high for Shelter Pharma Ltd is
The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.
The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
